Ibuprofen/Paracetamol (Ibuprofen, Paracetamol)

The ibuprofen component blocks cyclooxygenase enzymes, lowering peripheral prostaglandin production and reducing inflammation. Paracetamol acts mainly in the central nervous system, inhibiting COX activity and influencing serotonergic pathways, which together provide analgesic and antipyretic effects.

The appropriate dose is determined by a healthcare professional based on the individual's age, weight, and clinical condition. Prescribers follow local guidelines to select the correct strength and frequency, ensuring safe and effective therapy.

Safety in pregnancy and lactation has not been fully established. Women who are pregnant, planning pregnancy, or breastfeeding should consult their physician before using this combination to weigh potential benefits against risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The combination offers dual mechanisms: ibuprofen provides anti‑inflammatory action while paracetamol adds central analgesia and fever control. This can achieve comparable pain relief with potentially lower individual doses, but it also introduces combined safety considerations such as gastrointestinal and hepatic risks.

Store the product at ambient temperature, preferably below 25 °C, in its original packaging. Protect it from moisture, direct sunlight and excessive heat to maintain stability and potency throughout its shelf life.

The medication is taken orally with a full glass of water. It may be taken with or without food, although taking it with food can reduce the likelihood of stomach discomfort.

Serious adverse events include gastrointestinal bleeding or ulcer perforation, acute liver injury especially with overdose, severe skin reactions such as Stevens‑Johnson syndrome, anaphylactic allergic responses, and acute kidney impairment in susceptible individuals.

Individuals with known hypersensitivity to ibuprofen, paracetamol, or any component of the formulation should avoid it. It is also contraindicated in patients with active peptic ulcer disease, severe liver or kidney dysfunction, the third trimester of pregnancy, and in children for whom the dosage has not been established.